<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-pharmaceutics-12-00138">
 <label>12.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dalpiaz</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Pavan</surname>
    <given-names>B.</given-names>
   </name>
  </person-group>
  <article-title>Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux?</article-title>
  <source>Pharmaceutics</source>
  <year>2018</year>
  <volume>10</volume>
  <elocation-id>39</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics10020039</pub-id>
  <?supplied-pmid 29587409?>
  <pub-id pub-id-type="pmid">29587409</pub-id>
 </element-citation>
</ref>
